Long-term explantation risk in patients with chronic pain treated with spinal cord or dorsal root ganglion stimulation.
Kliment GatzinskyBeatrice BrinkKristin Lilja EyglóardóttirTobias HallénPublished in: Regional anesthesia and pain medicine (2024)
Although SCS and DRG stimulation are well-established and safe treatments for chronic pain, the long-term explantation risk remains high. The difference between manufacturers highlights the importance of technological evolution for improving therapy outcomes. Increased stringency in patient selection and follow-up strategies, as well as further development of device hardware and software technology for increased longevity, could possibly reduce long-term explantation risks.